Your browser doesn't support javascript.
loading
Farnesoid X receptor antagonist exacerbates dyslipidemia in mice.
Amano, Yuichiro; Yamakawa, Hiroko; Yonemori, Kazuko; Shimada, Mitsuyuki; Tozawa, Ryuichi.
  • Amano Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: yuichiro.amano@takeda.com.
  • Yamakawa H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Yonemori K; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Shimada M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
  • Tozawa R; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
Pharmacol Rep ; 70(1): 172-177, 2018 Feb.
Article en En | MEDLINE | ID: mdl-29367104

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Benzoatos / Receptores Citoplasmáticos y Nucleares / Dislipidemias / Lípidos / Hígado Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Benzoatos / Receptores Citoplasmáticos y Nucleares / Dislipidemias / Lípidos / Hígado Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article